CASE STUDY

Danish Hospital confirms PTS installation is safe for use before operation

Odense University Hospital


Odense, Denmark · 1,038 beds · View Website

Collaborators:
Mads Nybo, MD, PhD
Charlotte Gils, MD
Giles et al. Clin Chem Lab Med (2019)
(doi: 10.1515/cclm-2019-0881.)

 
pts tube wide web copy.jpg

“Investigating individual PTS lines with VitalQC and interpreting the impact on sample integrity means the PTS can be tested prior to clinical use.”

Dr. Charlotte Gils
Odense University Hospital

Odense Hospital.jpg
201022 web VitalApp.jpg

Challenge

Pneumatic tube systems (PTS) are widely used in hospitals for rapid blood sample transportation. However, PTS can affect sample integrity, and need to be validated to ensure samples arrive safely. Drs. Mads Nybo and Charlotte Gils at Odense University Hospital (OUH) needed to validate a single-tube PTS — something that can typically only be done with blood vials.

 
Motryx Solution.jpg

Solution

Drs. Nybo and Gils settled on VitalQC as it offered a solution with less blood. Because VitalVials have the same size and shape of blood tubes, they are uniquely suited to be transported by single-tube pneumatic systems.

 
Motryx Results.jpg

Results

Because of the link between vibration, measured by the VitalVials, and hemolysis seen in samples, OUH tested their PTS with much less blood. They confirmed that their system, as installed, was safe to transport samples to the lab.

VitalQC connected an increase in hemolysis with increasing transport speed in OUH’s system. OUH reduced the speed coming from one department by 1.2 m/s, which reduced hemolysis rejection from 16.4% to 12.9%. Based on previous studies, this change should have reduced sample rejection costs by 20,400 Euro per 10,000 tubes.

Read the study (PDF)

 
Motryx About Odense University Hospital.jpg

About Odense University Hospital

With 1,038 beds, Odense University Hospital is the largest hospital in Southern Denmark and one of four University Hospitals in Denmark. Every day, 6,000 samples are sent from departments to the laboratory.

OUH is planning a major new build, scheduled to open in 2022.

Based on VitalQC, OUH reduced the speed coming from one department by

1.2 m/s

This speed reduction reduced hemolysis rejection from

16.4% to 12.9%

This change should save the laboratory

20,400 € per 10,000 tubes.

Request a Demo

The best way to experience the value of VitalQC is in your own space.
We are happy to facilitate this demonstration and will provide you with a free, no-commitment trial.